Center for Scientific Review; Notice of Closed Meeting, 20672 [2024-06215]

Download as PDF 20672 Federal Register / Vol. 89, No. 58 / Monday, March 25, 2024 / Notices Open: May 31, 2024, 2:45 p.m. to 3:00 p.m. Agenda: Whole-genome sequencing in non-Alzheimer dementias: Progress, opportunities, and request for cloud resources (Concept) (Bryan J. Traynor, M.D., Ph.D., Senior Investigator, LNG). Place: National Institute on Aging, Biomedical Research Center, 251 Bayview Blvd., Baltimore, MD 21224 (Hybrid). Open: May 31, 2024, 3:00 p.m. to 3:15 p.m. Agenda: Discussion. Place: National Institute on Aging, Biomedical Research Center, 251 Bayview Blvd., Baltimore, MD 21224 (Hybrid). Closed: May 31, 2024, 3:15 p.m. to 4:30 p.m. Agenda: To review and evaluate executive Session (Final discussion of all Principal Investigators reviewed on all days.). Place: National Institute on Aging, Biomedical Research Center, 3C211/Virtual, 251 Bayview Blvd., Baltimore, MD 21224 (Hybrid). Closed: May 31, 2024, 4:30 p.m. to 4:30 p.m. Agenda: To review and evaluate adjourn. Place: National Institute on Aging, Biomedical Research Center, 3C211/Virtual, 251 Bayview Blvd., Baltimore, MD 21224 (Hybrid). Contact Person: Luigi Ferrucci, M.D., Ph.D., Scientific Director, National Institute on Aging, 251 Bayview Boulevard, Suite 100, Room 4C225, Baltimore, MD 21224, 410– 558–8110, LF27Z@NIH.GOV. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) Dated: March 19, 2024. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. Dated: March 19, 2024. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Computational and other Technologies. Date: April 11, 2024. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Contact Person: Marie-Jose Belanger, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Rm. 6188, MSC 7804, Bethesda, MD 20892, 301–435– 1267, belangerm@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) [FR Doc. 2024–06147 Filed 3–22–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health khammond on DSKJM1Z7X2PROD with NOTICES National Heart, Lung, and Blood Institute; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Heart, Lung, and Blood Institute Special Emphasis Panel, Mentored Career Development KAwards, March 28, 2024, 11 a.m. to 3 p.m., National Institutes of Health, Rockledge 1, 6705 Rockledge Drive, Bethesda, MD 20892, which was published in the Federal Register on February 20, 2024, FR Doc 2024–03384, 89 FR 12850. The meeting is being amended due to a change in time from 11 a.m.–3 p.m. to 10:30 a.m.–2:30 p.m. This meeting format will be a video assisted, and is closed to the public in accordance with provisions set forth in sections 552b(c)(4) and 552b(c)(6). VerDate Sep<11>2014 18:08 Mar 22, 2024 Jkt 262001 [FR Doc. 2024–06227 Filed 3–22–24; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration BILLING CODE 4140–01–P Fiscal Year (FY) 2024 Funding Opportunity DEPARTMENT OF HEALTH AND HUMAN SERVICES AGENCY: National Institutes of Health Center for Scientific Review; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Dated: March 19, 2024. David W. Freeman, Supervisory Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–06215 Filed 3–22–24; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 Substance Abuse and Mental Health Services Administration, Department of Health and Human Services (HHS). ACTION: Notice of intent to award a single source cooperative agreement to the Community-Based, AdvocacyFocused, Data-Driven, CoalitionBuilding Association (CADCA). This notice is to inform the public that the Substance Abuse and Mental Health Services Administration (SAMHSA) intends to award up to $675,000 per year for up to five (5) years to the Community-Based, AdvocacyFocused, Data-Driven, CoalitionBuilding Association (CADCA). The purpose of the award is to leverage existing resources to expand SAMHSA’s scope and prevention capacity; provide training and technical assistance to state and community prevention leaders, including members of anti-drug community coalitions from around the country who are committed to addressing the evolving needs of the behavioral health field; and to promote prevention workforce development. The training and workforce development activities supported through this cooperative agreement include SAMHSA’s Prevention Day and SAMHSA’s participation in the annual National Leadership Forum, the annual Mid-Year Training Institute of CADCA, and developing youth leaders across the three conferences/events listed above. FOR FURTHER INFORMATION CONTACT: David Lamont Wilson, Public Health Analyst, Substance Abuse and Mental Health Services Administration, 5600 Fishers Lane, Rockville, MD 20857, telephone 240–276–2588; email: david.wilson@samhsa.hhs.gov. SUPPLEMENTARY INFORMATION: Funding Opportunity Title: FY 2024 National Anti-Drug Coalitions Training and Workforce Development Cooperative Agreement (Short Title: Coalitions Training Cooperative Agreement), Notice of Funding Opportunity SP–24–003. Assistance Listing Number: 93.243. Authority: The Coalitions Training Cooperative Agreement is authorized under sections 509, 516 and 520A of the Public Health Service Act, as amended. Justification: Eligibility for this funding is limited to CADCA. CADCA is SUMMARY: E:\FR\FM\25MRN1.SGM 25MRN1

Agencies

[Federal Register Volume 89, Number 58 (Monday, March 25, 2024)]
[Notices]
[Page 20672]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-06215]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Small Business: Computational and other Technologies.
    Date: April 11, 2024.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Contact Person: Marie-Jose Belanger, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Rm. 6188, MSC 7804, Bethesda, MD 
20892, 301-435-1267, [email protected].

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: March 19, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee 
Policy.
[FR Doc. 2024-06215 Filed 3-22-24; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.